Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Virology|July 28, 2017
Effects of Inner Nuclear Membrane Proteins SUN1/UNC-84A and SUN2/UNC-84B on the Early Steps of HIV-1 InfectionTorsten Schaller, Lorenzo Bulli, Darja Pollpeter, et al.Plos Pathogens|November 30, 2018
Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restrictionMatthew D J Dicks, Gilberto Betancor, Jose M Jimenez-Guardeño, et al.Nature Microbiology|July 20, 2021
MX2-mediated innate immunity against HIV-1 is regulated by serine phosphorylationGilberto Betancor, Jose M Jimenez-Guardeño, Steven Lynham, et al.Biorxiv : the Preprint Server for Biology|May 18, 2026
MX2 Mediates Collapse of the HIV-1 CapsidAndrew Goodale, Szu-Wei Huang, Nathalia Almeida, et al.The Journal of Infectious Diseases|August 17, 2011
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapyRoger Paredes, Maria Carmen Puertas, Wendy Bannister, et al.Plos One|April 7, 2021
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic waveNicola Sweeney, Blair Merrick, Rui Pedro Galão, et al.The Analyst|July 9, 2020
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndromeAndrew M Shaw, Christopher Hyde, Blair Merrick, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2021
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmissionLuke B Snell, Chloe L Fisher, Usman Taj, et al.Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.Plos One|September 15, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivationMaria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.Pageof 3